• About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact
  • About Us
    • What We Do
    • Our Story
    • Meet Our Team
  • Products
    • COVID-19 Response
      • COVID-19 Home Test
      • QIAreach COVID
      • ellume·lab COVID Tests
      • Swab+Drop COVID Self-Swab Kit
    • Consumer Products
      • COVID-19 Home Test
      • Influenza Home Test
    • Professional Products
      • ellume·lab
      • Swab+Drop Self-Swab Kit
    • Global Public Health Solutions
      • COVID-19
      • Tuberculosis
      • Pandemic Influenza
  • Our Tech
  • News
    • Corporate Announcements
    • Media
  • Careers
    • Australia
    • United States
  • Contact
Ellume founder Dr Parsons on COVID testing, Omicron

Ellume founder Dr Parsons on COVID testing, Omicron

December 3, 2021 Ellume Founder, CEO and Managing Director Dr Sean Parsons spoke with Haidi Stroud-Watts on the “Bloomberg Daybreak: Australia” program about the company’s work in developing an at-home covid test and the technology behind it.
Read More
Ellume named Popular Science Best of What’s New 2021

Ellume named Popular Science Best of What’s New 2021

Read More
Ellume wins AFR BOSS Most Innovative Company Award

Ellume wins AFR BOSS Most Innovative Company Award

Read More
Push to allow at-home COVID tests in Australia

Push to allow at-home COVID tests in Australia

20 July, 2021 Ellume Founder, CEO and Managing Director Dr Sean Parsons spoke with Peta Credlin on Sky News’ Credlin program about how Ellume’s range of COVID-19 tests are being sold in the U.S. to support efforts to combat the spread of COVID-19 within the community.
Read More
Why Aussie startup Ellume’s home-testing tech should help us in the COVID-19 recovery, but can’t

Why Aussie startup Ellume’s home-testing tech should help us in the COVID-19 recovery, but can’t

An Aussie medtech company is leading the charge in home-testing for COVID-19, but legislation means Aussies — and the small businesses that employ them — are not able to reap the benefits. That’s according to Dr Sean Parsons, founder and chief of medtech Ellume, which has developed a COVID-19 home testing kit already in use […]
Read More
An Australian firm producing home COVID-19 tests for the US market has called on the federal government to reconsider its ban

An Australian firm producing home COVID-19 tests for the US market has called on the federal government to reconsider its ban

The founder of an Australian firm which produces at-home COVID-19 testing kits says the federal government appears “unwilling” to consider testing alternatives. Ellume founder Sean Parsons told “Sunrise” the kits, which have been approved for use in the U.S., could be helpful during lockdowns to reduce long queues for traditional testing centres. Therapeutic goods legislation […]
Read More
Rapid COVID-19 Testing Device, Sunrise Interview with Ellume CEO Dr Sean Parsons

Rapid COVID-19 Testing Device, Sunrise Interview with Ellume CEO Dr Sean Parsons

July 19, 2021 Ellume Founder, CEO and Managing Director Dr Sean Parsons was interviewed by Channel 7’s David Koch on the Sunrise program about how Ellume’s COVID-19 Home Test can contribute to Australia’s pandemic recovery plan. “The government seems to be unwilling to explore how these new technologies can be part of the future” Queensland […]
Read More
New rapid COVID testing options coming to Delta; Purchase and pack for smooth U.S. re-entry

New rapid COVID testing options coming to Delta; Purchase and pack for smooth U.S. re-entry

In partnership with AZOVA, now available Ellume COVID-19 Home Tests are single-packaged and offer highly accurate results in minutes. Delta offering new in-home testing options for purchase that provide results in minutes CDC-accepted tests give customers peace of mind as international travel reopens Delta customers now have more ways to meet COVID-19 test requirements introduced […]
Read More
Channel 10’s new Advancing Australia series features Ellume CEO Dr Sean Parsons

Channel 10’s new Advancing Australia series features Ellume CEO Dr Sean Parsons

12 June 2021 Ellume Founder, CEO and Managing Director Dr Sean Parsons appeared on Channel 10’s new landmark “Advancing Australia” documentary series which uncovers inspirational stories of ordinary people who are doing extraordinary things to make our country a better place. Episode 11 can be viewed on-demand at the 10 play Advancing Australia website.
Read More
More at-home COVID tests coming to the market, and made in Maryland

More at-home COVID tests coming to the market, and made in Maryland

May 10, 2021 An Australian company that recently began selling a rapid at-home COVID-19 test plans to open its first U.S. production plant in Maryland later this year. Ellume plans to announce today that it will make the test kits in Ballenger Creek, just south of Frederick, and eventually employ 1,500 people to make up […]
Read More
Page 1 of 41234
Recent Posts
  • Free tests for blind and low vision people.
  • Ellume founder Dr Parsons on COVID testing, Omicron
  • Ellume named Popular Science Best of What’s New 2021
  • Ellume wins AFR BOSS Most Innovative Company Award
  • QIAGEN receives U.S. FDA emergency use authorization for rapid portable SARS-CoV-2 antigen test
Archives
Categories
Business
Scroll
ellume logo white
Menu

Home
About Us
COVID-19 Response
Consumer Products
Professional Products
Global Public Health Solutions
Our Tech
News

Quick Links

Contact Us
Terms of Use
Privacy Policy
Whistleblower Policy

Some products pending regulatory clearance and not available for sale. © Ellume Limited 2022
ABN 13 141 767 660